Kay L. Double

8.8k total citations · 1 hit paper
106 papers, 6.7k citations indexed

About

Kay L. Double is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Kay L. Double has authored 106 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Neurology, 31 papers in Cellular and Molecular Neuroscience and 23 papers in Neurology. Recurrent topics in Kay L. Double's work include Parkinson's Disease Mechanisms and Treatments (55 papers), Neurological disorders and treatments (17 papers) and melanin and skin pigmentation (16 papers). Kay L. Double is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (55 papers), Neurological disorders and treatments (17 papers) and melanin and skin pigmentation (16 papers). Kay L. Double collaborates with scholars based in Australia, Germany and United States. Kay L. Double's co-authors include Dominic J. Hare, Glenda M. Halliday, Peter Riederer, M. Gerlach, Benjamin G. Trist, Moussa B. H. Youdim, Manfred Gerlach, H. Fedorow, Luigi Zecca and Stefanie Reyes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Kay L. Double

102 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

2019 520 citations Benjamin G. Trist, Dominic J. Hare et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kay L. Double Australia	46	2.8k	1.8k	1.8k	1.1k	1.1k	106	6.7k
Dorit Ben‐Shachar Israel	47	2.0k 0.7×	2.0k 1.1×	2.6k 1.4×	1.1k 0.9×	1.6k 1.5×	102	7.5k
Oliver Bandmann United Kingdom	41	2.5k 0.9×	1.5k 0.8×	2.0k 1.1×	923 0.8×	779 0.7×	123	6.0k
Fabio A. Zucca Italy	36	2.5k 0.9×	1.5k 0.8×	1.7k 0.9×	1.0k 0.9×	1.2k 1.1×	54	6.8k
Manfred Gerlach Germany	44	2.6k 0.9×	2.0k 1.1×	1.7k 0.9×	1.1k 1.0×	1.1k 1.0×	174	6.7k
M. Gerlach Germany	40	2.3k 0.8×	1.8k 1.0×	1.4k 0.8×	686 0.6×	766 0.7×	122	5.7k
Yoshiaki Furukawa Japan	44	3.4k 1.2×	2.1k 1.2×	2.3k 1.3×	1.1k 1.0×	859 0.8×	131	6.4k
Susanne A. Schneider Germany	47	3.9k 1.4×	2.4k 1.3×	2.0k 1.1×	833 0.7×	2.2k 2.0×	164	7.0k
Rita Raisman‐Vozari France	42	2.2k 0.8×	3.0k 1.7×	1.6k 0.9×	1.1k 0.9×	993 0.9×	141	6.2k
Masato Asanuma Japan	45	1.5k 0.5×	2.3k 1.3×	2.1k 1.2×	868 0.8×	1.2k 1.1×	235	6.7k
Ikuo Tooyama Japan	48	1.4k 0.5×	2.2k 1.2×	2.9k 1.6×	2.2k 2.0×	1.8k 1.6×	300	8.0k

Countries citing papers authored by Kay L. Double

Since Specialization

Citations

This map shows the geographic impact of Kay L. Double's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay L. Double with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay L. Double more than expected).

Fields of papers citing papers by Kay L. Double

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay L. Double. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay L. Double. The network helps show where Kay L. Double may publish in the future.

Co-authorship network of co-authors of Kay L. Double

This figure shows the co-authorship network connecting the top 25 collaborators of Kay L. Double. A scholar is included among the top collaborators of Kay L. Double based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay L. Double. Kay L. Double is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Trist, Benjamin G., Veronica Cottam, Michael Kuligowski, et al.. (2025). Imaging Copper Levels during Life in the Brain and beyond Using a Fluorescent Copper Sensor with Multimodal Capacity. Chemical & Biomedical Imaging. 3(10). 653–662.

2.

Cottam, Veronica, Benjamin G. Trist, Nguyen Tuong Pham, et al.. (2024). Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu ²⁺ in the Brain. ACS Sensors. 9(6). 2858–2868. 27 indexed citations

3.

Penning, Louis C., Marina Berenguer, Anna Członkowska, et al.. (2023). A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment. Biomedicines. 11(2). 420–420. 6 indexed citations

4.

Trist, Benjamin G., et al.. (2022). Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis. npj Parkinson s Disease. 8(1). 83–83. 5 indexed citations

5.

Roudeau, Stéphane, Benjamin G. Trist, Asunción Carmona, et al.. (2021). Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological Workflow. Analytical Chemistry. 93(32). 11108–11115. 5 indexed citations

6.

Trist, Benjamin G., James B. Hilton, Dominic J. Hare, Peter J. Crouch, & Kay L. Double. (2020). Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic. Angewandte Chemie. 133(17). 9299–9330. 7 indexed citations

7.

Genoud, Sian, Michael W. Jones, Benjamin G. Trist, et al.. (2020). Simultaneous structural and elemental nano-imaging of human brain tissue. Chemical Science. 11(33). 8919–8927. 16 indexed citations

8.

Trist, Benjamin G., James B. Hilton, Dominic J. Hare, Peter J. Crouch, & Kay L. Double. (2020). Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic. Angewandte Chemie International Edition. 60(17). 9215–9246. 152 indexed citations

9.

Trist, Benjamin G., Dominic J. Hare, & Kay L. Double. (2018). A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress. Cell chemical biology. 25(7). 807–816. 36 indexed citations

10.

Witting, Paul K., et al.. (2017). Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease. Metallomics. 9(7). 852–864. 26 indexed citations

11.

Trist, Benjamin G., Katherine M. Davies, Veronica Cottam, et al.. (2017). Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson’s disease brain. Acta Neuropathologica. 134(1). 113–127. 85 indexed citations

12.

Hare, Dominic J., Bárbara Rita Cardoso, Erika P. Raven, et al.. (2017). Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease. npj Parkinson s Disease. 3(1). 1–1. 57 indexed citations

13.

Reyes, Stefanie, Veronica Cottam, Deniz Kirik, Kay L. Double, & Glenda M. Halliday. (2013). Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra. Movement Disorders. 28(10). 1351–1359. 23 indexed citations

14.

Reyes, Stefanie, YuHong Fu, Kay L. Double, et al.. (2012). Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease. Neurobiology of Aging. 34(3). 873–886. 45 indexed citations

15.

Werry, Eryn L., et al.. (2010). Effect of age on proliferation‐regulating factors in human adult neurogenic regions. Journal of Neurochemistry. 115(4). 956–964. 21 indexed citations

16.

Dedov, Vadim N., et al.. (2007). Lipid content determines aggregation of neuromelanin granules in vitro. PubMed. 35–38. 4 indexed citations

17.

Gerlach, M., Kay L. Double, Moussa B. H. Youdim, & Peter Riederer. (2006). Potential sources of increased iron in the substantia nigra of parkinsonian patients. PubMed. 133–142. 85 indexed citations

18.

Halliday, Glenda M., Melissa Broe, Poul Henning Jensen, et al.. (2005). α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain. 128(11). 2654–2664. 161 indexed citations

19.

Foley, Peter, M. Gerlach, Kay L. Double, & Peter Riederer. (2003). Dopamine receptor agonists in the therapy of Parkinson?s disease. Journal of Neural Transmission. 111(10-11). 1375–1446. 67 indexed citations

20.

Halliday, Glenda M., D.A. McRitchie, Virginia Macdonald, et al.. (1998). Regional Specificity of Brain Atrophy in Huntington's Disease. Experimental Neurology. 154(2). 663–672. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact